Muzammil Mansuri joined F-Prime in January 2020 as a Venture Partner, based in Cambridge. He has over 35 years of experience in senior R&D roles in the biopharmaceutical industry.
What Muzammil can write
F-Prime Capital writes $1M to $30M+ checks, larger than 83% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: F-Prime Capital.Career
- Bristol Myers · bench medicinal chemist
- Flagship Ventures (now Flagship Pioneering) · General Partner
- Gilead Sciences · Senior Vice President, Research and Development Strategy and Business Development
- Sanofi · Executive Vice President, Strategy, Business Development, and Licensing
- F-Prime · Venture PartnerNow
- Flagship Ventures · General Partner
- CGI Pharmaceuticals · Chairman and CEO
- F-Prime Capital · Venture PartnerNow
Focus
Education
Also at F-Prime Capital
Partners like Muzammil
At firms with a similar stage, sector and check size.
Alert me when F-Prime Capital is active
One email when Muzammil's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Muzammil Mansuri?
Muzammil Mansuri joined F-Prime in January 2020 as a Venture Partner, based in Cambridge. He has over 35 years of experience in senior R&D roles in the biopharmaceutical industry.
How much does Muzammil Mansuri invest?
Muzammil Mansuri invests through F-Prime Capital, which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.
How do I pitch Muzammil Mansuri?
Email [email protected], the firm's inbox for founders, and name Muzammil in the subject. A warm intro from a founder F-Prime Capital backed works better.
What did Muzammil Mansuri do before F-Prime Capital?
bench medicinal chemist at Bristol Myers; General Partner at Flagship Ventures (now Flagship Pioneering); Senior Vice President, Research and Development Strategy and Business Development at Gilead Sciences; Executive Vice President, Strategy, Business Development, and Licensing at Sanofi; General Partner at Flagship Ventures; Chairman and CEO at CGI Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.